Titan Machinery Inc. Announces Results for Fiscal Fourth

Titan Machinery Inc. Announces Results for Fiscal Fourth

- Revenue for Fiscal 2023 Increased 29.1% to $2.2 billion - - Record Fiscal 2023 GAAP EPS of $4.49 and Adjusted EPS of $4.52, an increase of......

Atour Lifestyle Holdings Limited to Report Fourth Quarter

Atour Lifestyle Holdings Limited to Report Fourth Quarter

SHANGHAI, China, March 16, 2023 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and......

Hywin Holdings to Announce First Half of Fiscal Year 2023

Hywin Holdings to Announce First Half of Fiscal Year 2023

SHANGHAI, China, March 16, 2023 (GLOBE NEWSWIRE) -- Hywin Holdings Ltd. (“Hywin,” or the “Company”) (NASDAQ: HYW), a leading independent wealth......

Huize Holding Limited to Report Fourth Quarter and Full

Huize Holding Limited to Report Fourth Quarter and Full

SHENZHEN, China, March 16, 2023 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance......

CORRECTION -- ToughBuilt Industries Announces Fourth

CORRECTION -- ToughBuilt Industries Announces Fourth

Record fourth quarter year revenue of $29.6 million, with 20% year-over-year growthRecord full year revenue of $94.9 million with 36% year-over-year growth......

Nano Dimension’s Chairman & CEO Responds to the Latest

Nano Dimension’s Chairman & CEO Responds to the Latest

A Detailed Study of Anson’s Published Track Record......

Ventyx Biosciences to Report Fourth Quarter and Full Year

Ventyx Biosciences to Report Fourth Quarter and Full Year

ENCINITAS, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company......

Silo Pharma Announces Positive Results from IND-Enabling

Silo Pharma Announces Positive Results from IND-Enabling

ENGLEWOOD CLIFFS, NJ, March 15, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical......

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 44
  • menu
    menu